ambr® 15

The generation of biologic-producing cell lines comprises numerous time-consuming, expensive, and often technically challenging steps.

In this new eBook, we examine these challenges in greater detail and explore a range of intelligent analytical solutions that can be incorporated into cell line development workflows to eliminate bottlenecks in clone selection, fast-track development timelines, optimize CQAs, and reduce costs.

Download your free copy today to learn more about:

• Critical steps in cell line development
• Areas to improve efficiency
• Overcoming bottlenecks through streamlined clone selection
• Accelerating process optimization with integrated analysis tools
  

In this brochure, Sartorius introduces the Ambr® 15 Cell Culture Generation 2, an automated, high throughput microscale bioreactor system that replicates laboratory scale bioreactor performance.

Download this exclusive eBook to access a complete guide with all the information you need to help you make the right decisions for your lab, including key considerations, top tips, expert insight, and useful resources for preclinical and clinical-stage CAR-T cell development. Discover the best technologies available for CAR-T cell therapy workflows and find out more about:

• In vitro assays and sample preparation
• In vitro workflows
• CAR construct delivery
• Quality control (QC) and quality assurance (QA)

This poster demonstrates the efficiency of the ambr 15 micro bioreactor platform for microbial screening applications.

Commercialization of a biologic is a lengthy and expensive process. Successful cell line development (CLD) is heavily dependent upon balancing time and resources with acquiring high-quality data for informed decisions. Each stage of the CLD workflow has challenges and there is a real need for advanced strategies and intelligent use of innovative solutions.

The CellCelector, iQue®, Octet®, and Ambr® 15 CC platforms are perfectly designed to seamlessly work together to streamline the early CLD workflow, enabling data-driven decisions and reducing risk during later stages of biologic development. In this webinar, Dr. Fern Slingsby, Ambr Product Specialist at Sartorius and Dr. Daryl Cole, Applications Scientist at Sartorius, will explain how integration of these platforms can be achieved, and where they best fit into the cell line development workflow.

Key learning objectives

• Learn about the early CLD workflow and the bottlenecks associated with the various stages
• Discover instruments which are suited to high-throughput demands and where they fit into the CLD workflow
• Establish a strategy for a simplified approach to cell line development

Who should attend?

• Analytical scientists and researchers involved in early drug discovery and cell line development
• Bioprocessing engineers and scientists
• Process development engineers and scientists
• Lab managers

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

In this video, Dr Lars Knoch and Dr Dagmar Simons introduce the solutions that Sartorius can provide across the molecule and cell line development process. Sartorius offers practical solutions from lead discovery to cell banking of the master cell line, giving research scientists the flexibility to develop their own workflows whilst keeping within the Sartorius product range.

Unique technology portfolio enables design space characterization, effective translation to the large-scale and enhanced process analytics

Presents data showing how the system can be used to support batch and high density fed batch microbial screening